---
title: "Nausea"
description: "Nausea is the most common GLP-1 side effect during dose titration, usually improving within weeks."
canonical: "https://www.kesho.health/glossary/nausea"
markdown_url: "https://www.kesho.health/md/glossary/nausea"
language: "en-IN"
---

# Nausea

**Canonical HTML:** https://www.kesho.health/glossary/nausea  
**Markdown:** https://www.kesho.health/md/glossary/nausea

## Definition

Nausea is an uncomfortable urge to vomit, frequently experienced when starting or increasing GLP-1 receptor agonist doses.

## Extended

Caused partly by slowed gastric emptying. Smaller meals, avoiding greasy foods, and gradual titration help. Persistent vomiting requires medical attention due to dehydration risk. In India, these concepts appear in RSSDI and ICMR guidance for type 2 diabetes and obesity care—always confirm details with your prescribing physician.

## Learn more

[Full guide](https://www.kesho.health/blog/glp-1-side-effects-safety) · [MD](https://www.kesho.health/md/blog/glp-1-side-effects-safety)

## Related terms

- [dose-titration](https://www.kesho.health/glossary/dose-titration)
- [gastric-emptying](https://www.kesho.health/glossary/gastric-emptying)
- [glp-1-side-effects](https://www.kesho.health/glossary/glp-1-side-effects)